Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes

@article{Trofimovitch2019PharmacologyUL,
  title={Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes},
  author={Diana Trofimovitch and S. Baumrucker},
  journal={American Journal of Hospice and Palliative Medicine®},
  year={2019},
  volume={36},
  pages={907 - 912}
}
  • Diana Trofimovitch, S. Baumrucker
  • Published 2019
  • Medicine
  • American Journal of Hospice and Palliative Medicine®
  • Pain can have a devastating effect on the quality of life of patients in palliative medicine. Thus far, majority of research has been centered on opioid-based pain management, with a limited empirical evidence for the use of nonopioid medications in palliative care. However, opioid and nonopioid medications such as nonsteroidal anti-inflammatory drugs have their limitations in the clinical use due to risk of adverse effects, therefore, there is a need for more research to be directed to finding… CONTINUE READING
    5 Citations

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    Interstitial cystitis/painful bladder syndrome (IC/PBS) is a debilitating condition with symptoms of urinary urgency, frequency, nocturia (waking up at night to void), and pain… Expand
    ConditionsBladder Pain Syndrome, Interstitial Cystitis, Low-dose Naltrexone, (+3 more)
    InterventionDrug

    References

    SHOWING 1-10 OF 30 REFERENCES
    Off-label, low-dose naltrexone for refractory chronic low back pain.
    • 7
    • PDF
    The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain
    • 92
    • Highly Influential
    • PDF
    Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization
    • 16
    • Highly Influential
    • PDF
    Off-Label, Low-Dose Naltrexone for Refractory Painful Diabetic Neuropathy.
    • 10
    • PDF
    Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy.
    • 16
    Opioids and the treatment of chronic pain: controversies, current status, and future directions.
    • 363
    • PDF
    Low-Dose Naltrexone Therapy Improves Active Crohn's Disease
    • 113
    • PDF
    Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study.
    • 123
    • PDF